VerImmune
Manufacturing · District of Columbia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7144 13th Pl NW Ste 2200, Washington, Di...Website
www.verimmune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About VerImmune
VerImmune is focused on pioneering Anti-Tumor Immune Redirection (AIR), a novel therapy that utilizes pre-existing immune memory from pathogens or childhood vaccines to target and destroy cancer cells. The company aims to address the growing need for effective cancer treatments, with over 14 million new cases diagnosed annually and significant expenditures on cancer care. Their strategy involves screening patients for pre-existing immunity and modifying tumor cells to mimic virally infected cells, leading to tumor cell death through immune redirection. VerImmune seeks to connect with industry partners to further advance their innovative approach to cancer therapy.Explore more
VerImmune Org Chart
DF
Director, Project Management
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VerImmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if VerImmune has recently received funding, and reach out quickly before it becomes old news!
Click to see if VerImmune had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at VerImmune
VerImmune, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once VerImmune has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when VerImmune launches new products
Check out if VerImmune is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on VerImmune recently announced quarterly report
Recommended Actions
Find VP level buyers at VerImmune
Find 2 more new buyers
Compare Similar Companies to VerImmune
Compare insights from companies similar to VerImmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
VerImmune is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VerImmune is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VerImmune.
VerImmune financials insights
Gather financial insights about VerImmune, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$5.5M
VerImmune Tech Stack
A closer look at the technologies used by VerImmune
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Funding
Funding
VerImmune News & Media
VerImmune Completes $4.5M First Closing of Pre-Series A
BETHESDA, MD, VerImmune, a venture-backed biotechnology company, announced the successful first closing of $4.5 million in its Pre-Series A financing round.VerImmune Completes $4.5 Million First Closing of Pre-Series A Financing, Strengthens Board with Two Accomplished Biotechnology Executives
BETHESDA, Md. and SINGAPORE, Sept. 23, 2024 /PRNewswire/ -- VerImmune Inc., ("VerImmune"), a venture-backed biotechnology company developing a groundbreaking Virus-inspired Particle (ViP™) platform technology, today announced the successful first closing of $4.5 million in its Pre-Series...VerImmune Inc. announces over $3M Additional Funding
Funding follows VerImmune's successful FDA pre-IND meeting as well as completion of a key process development milestone. Participation occurred from existing investors as well as a pharmaceutical partner. Proceeds will be used to accelerate GLP/GMP activities towards an IND for...VerImmune Announces Positive Pre-IND Meeting with FDA
Favorable feedback and clear development path for VERI-101, a novel Immunotherapy WASHINGTON, May 22, 2023 /PRNewswire/ -- VerImmune Inc ("VerImmune"), an early-stage biotechnology company specializing in the development of innovative products based on a novel Virus-inspired Particle...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VerImmune
Sign Up For FreeTo access detailed company insights
VerImmune is focused on pioneering Anti-Tumor Immune Redirection (AIR), a novel therapy that utilizes pre-existing immune memory from pathogens or childhood vaccines to target and destroy cancer cells. The company aims to address the growing need for effective cancer treatments, with over 14 million new cases diagnosed annually and significant expe... Read More
